Julie F. Mengucci

Synaptic Research (United States) — United States

Neuroscience · Life Sciences

9h-index278citations11works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurotransmitter Receptor Influence on Behavior(3), Pharmacology and Obesity Treatment(3), Pain Mechanisms and Treatments(2), Functional Brain Connectivity Studies(2), Attention Deficit Hyperactivity Disorder(2)

Publications11 total

Chromium Picolinate (CrP) a putative anti-obesity nutrient induces changes in body composition as a function of the Taq1 dopamine D2 receptor polymorphisms in a randomized double-blind placebo controlled study
2007· 12 cited
Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: Evidence supported by structural equation modeling (SEM) parameter estimates
AGE·2007· 7 citedOpen Access
Gene Narcotic Attenuation Program attenuates substance use disorder, a clinical subtype of reward deficiency syndrome
Advances in Therapy·2007· 33 cited
Synaptamine (SG8839),TM An Amino-Acid Enkephalinase Inhibition Nutraceutical Improves Recovery of Alcoholics, A Subtype of Reward Deficiency Syndrome (RDS)
Trends in Applied Sciences Research·2007· 26 citedOpen Access
Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: A hypothesis
Medical Hypotheses·2007· 50 cited
Reward deficiency syndrome in obesity: A preliminary cross-sectional trial with a genotrim variant
Advances in Therapy·2006· 58 cited
The H-Wave® small muscle fiber stimulator, a nonpharmacologic alternative for the treatment of chronic soft-tissue injury and neuropathic pain: an extended population observational study
Advances in Therapy·2006· 12 cited
Delayed P300 latency correlates with abnormal Test of Variables of Attention (TOVA) in adults and predicts early cognitive decline in a clinical setting
Advances in Therapy·2006· 31 cited
H-wave®, a nonpharmacologic alternative for the treatment of patients with chronic soft tissue inflammation and neuropathic pain: A preliminary statistical outcome study
Advances in Therapy·2006· 12 cited
Nutrigenomics and pharmacogenomics: a scientific wonderland
Social Science Information·2006· 6 cited
Neurogenetic interactions and aberrant behavioral co-morbidity of attention deficit hyperactivity disorder (ADHD): dispelling myths
Theoretical Biology and Medical Modelling·2005· 31 citedOpen Access

Frequent Co-authors

Thomas J.H. Chen(11), Seth H. Blum(11), Kenneth Blum(9), Bernard W. Downs(8), Brian Meshkin(7), Eric R. Braverman(7), Vanessa Arcuri(7), Roger L. Waite(6), John Schoolfield(5), Michael Varshavskiy(4), Brian Meshkin(4), Manuel Martinez-Pons(3), Kenneth Blum(2), Tomás Palomo(2), David E. Comings(2), Manuel Martínez Pons(2), Thomas J. Prihoda(2), Nicholas A. DiNubile(2), Cory A. Gordon(1), Roger Deutsch(1)